The FDA has cleared the use of GSK’s Blujepa for the treatment of uncomplicated urogenital gonorrhea, unlocking the first new ...
The 2024–2025 formulations of COVID-19 vaccines had an effectiveness rate of 76% at preventing emergency or urgent care ...
Generalized myasthenia gravis is Uplizna’s second new indication this year, after the FDA cleared the anti-CD19 antibody for ...
With five CDER leaders in one year and regulatory proposals coming “by fiat,” the FDA is only making it more difficult to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback